Corteva, Inc.
General ticker "CTVA" information:
- Sector: Materials
- Industry: Agricultural Inputs
- Capitalization: $44.9B (TTM average)
Corteva, Inc. follows the US Stock Market performance with the rate: 38.3%.
Estimated limits based on current volatility of 1.1%: low 69.06$, high 70.58$
Factors to consider:
- Company included in S&P500 list
- Company pays dividends (quarterly): last record date 2025-12-01, amount 0.18$ (Y1.03%)
- Total employees count: 22000 (-2.2%) as of 2024
- US accounted for 46.5% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Geopolitical risks, Economic downturns and volatility, Cybersecurity threats, Supply chain disruptions, Environmental liabilities
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [45.90$, 71.44$]
- 2025-12-31 to 2026-12-31 estimated range: [48.78$, 75.52$]
Financial Metrics affecting the CTVA estimates:
- Negative: with PPE of 22.3 at the end of fiscal year the price was high
- Positive: 7.54 < Operating profit margin, % of 12.40
- Positive: 42.53 < Shareholder equity ratio, % of 58.27 <= 64.17
- Positive: 1.77 < Return on assets ratio (scaled to [-100,100]) of 2.07
- Negative: Industry operating cash flow per share per price (median), % of 4.30 <= 5.42
- Positive: Inventory ratio change, % of -5.60 <= -0.76
Short-term CTVA quotes
Relationship graph
Long-term CTVA plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $17,455.00MM | $17,226.00MM | $16,908.00MM |
| Operating Expenses | $15,527.00MM | $15,116.00MM | $14,812.00MM |
| Operating Income | $1,928.00MM | $2,110.00MM | $2,096.00MM |
| Non-Operating Income | $-502.00MM | $-1,017.00MM | $-821.00MM |
| Interest Expense | $79.00MM | $233.00MM | $233.00MM |
| R&D Expense | $1,216.00MM | $1,337.00MM | $1,402.00MM |
| Income(Loss) | $1,426.00MM | $1,093.00MM | $1,275.00MM |
| Taxes | $210.00MM | $152.00MM | $412.00MM |
| Other Income(Loss) | $-58.00MM | $-194.00MM | $56.00MM |
| Profit(Loss)* | $1,147.00MM | $735.00MM | $907.00MM |
| Stockholders Equity | $25,302.00MM | $25,037.00MM | $23,789.00MM |
| Inventory | $6,811.00MM | $6,899.00MM | $5,432.00MM |
| Assets | $42,618.00MM | $42,996.00MM | $40,825.00MM |
| Operating Cash Flow | $872.00MM | $1,769.00MM | $2,145.00MM |
| Capital expenditure | $605.00MM | $595.00MM | $597.00MM |
| Investing Cash Flow | $-632.00MM | $-1,987.00MM | $-589.00MM |
| Financing Cash Flow | $-1,180.00MM | $-99.00MM | $-1,199.00MM |
| Earnings Per Share** | $1.59 | $1.04 | $1.31 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.